广济药业(000952) - 2017年3月23日投资者关系活动记录表

Group 1: Environmental Regulations - Recent tightening of environmental regulations presents a double-edged sword for the company. Increased investment is required for compliance, such as relocating the factory to a more suitable industrial park to address environmental constraints [3] - Stricter environmental policies have effectively suppressed the production capacity of smaller enterprises, creating industry barriers [3] Group 2: Future Development Strategies - Advancement of VB6GMP certification is a key focus for future growth [3] - Exploration of external development paths includes horizontal product development and vertical mergers and acquisitions within the supply chain [3] - Establishment of a group management system has been completed, forming a clear, efficient, and scientifically divided management structure with three production bases, three centers, and one management headquarters [3] - Relocation of the management headquarters from Wuxue to Wuhan in 2017 aims to resolve regional limitations and talent shortages [3]